コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 me P450 or phase II conjugating enzymes (UDP-glucuronosyltransferase).
2 ficiency of the hepatic enzyme bilirubin-UDP-glucuronosyltransferase.
3 plained by deletion of a uridine diphosphate glucuronosyltransferase.
4 onic acid in the liver via the action of UDP-glucuronosyltransferases.
5 GUX2 and GUX4, have activity as xylan alpha-glucuronosyltransferases.
6 nsferases, glutathione transferases, and UDP-glucuronosyltransferases.
7 osyltransferase, INOSITOL PHOSPHORYLCERAMIDE GLUCURONOSYLTRANSFERASE 1 (IPUT1), which is the first en
9 A polymorphism in the promoter of the UDP-glucuronosyltransferase 1 (UGT1A1) gene has been shown t
11 01A1, glutathione S-transferase Ya1, and UDP-glucuronosyltransferase 1*6 are apparently potentiated t
12 (pfu) intravenously) in adult bilirubin-UDP-glucuronosyltransferase-1 (BUGT1)-deficient Gunn rats re
13 ance to adenoviral antigens in bilirubin-UDP-glucuronosyltransferase-1 (BUGT1)-deficient Gunn rats.
14 gastroduodenostomy tubes into bilirubin-UDP-glucuronosyltransferase-1 (BUGT1)-deficient jaundiced Gu
16 ransferase (pSV2-CAT) or human bilirubin-UDP-glucuronosyltransferase-1 (pSVK3-hBUGT1) genes were comp
17 ns of bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) completely or partial
18 x promoter spanning 218 kb, the phase II UDP-glucuronosyltransferase 1A (UGT1) gene encodes at least
19 esult in part from delayed expression of UDP-glucuronosyltransferase 1A1 (UGT1A1) and the inability t
21 ated the impact of oral iAs treatment on UDP-glucuronosyltransferase 1A1 (UGT1A1) expression and bili
22 aluated the impact of lactational TCS on UDP-glucuronosyltransferase 1A1 (UGT1A1) expression and bili
28 ), CAR, cytochrome P-450 2b10 (Cyp2b10), UDP-glucuronosyltransferase 1a1 (Ugt1a1), sulfotransferase 2
29 lack the enzyme uridine diphosphoglucuronate glucuronosyltransferase 1A1 (UGT1A1), the absence of whi
30 in turn is detoxified primarily through UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed glucuroni
32 P7A1), CYP27A1, CYP8B1, uridine 5'-diphospho-glucuronosyltransferase 1A1, 1A3, 1A4, 1A6, hydroxystero
36 uted isozymes encoded at the UGT1 locus, UDP-glucuronosyltransferase 1A10 (UGT1A10) metabolizes a num
37 tutive or ligand-induced CYP1A1; CYP1A2; UDP glucuronosyltransferase 1A2; NAD(P)H dehydrogenase, quin
41 tion and stemness by inducing the enzyme UDP-glucuronosyltransferase 2B15 (UGT2B15), which promotes t
46 n permethrin resistant mosquitoes included a glucuronosyltransferase (AAEL014279-RA) and the glutathi
47 ly due to interindividual differences in UDP-glucuronosyltransferase activity and/or excretion pathwa
49 This paralleled the hepatic bilirubin-UDP-glucuronosyltransferase activity, which was above 50% of
50 binant adenovirus (Ad), adenovirus human UDP-glucuronosyltransferase (Ad-hBUGT1) carrying the hBUGT1
53 , we quantified androgen dependence of UGDH, glucuronosyltransferase, and HA synthase expression.
55 eme oxygenase, biliverdin reductase, and UDP-glucuronosyltransferases, and there was concordance with
56 a normal form of uridinediphosphoglucuronate glucuronosyltransferase because of a defect in the promo
58 human bilirubin-uridine-diphosphoglucuronate-glucuronosyltransferase (BUGT) genes, into BUGT-deficien
59 noviral antigens, we immunized bilirubin-UDP-glucuronosyltransferase (BUGT)-deficient jaundiced Gunn
60 ll as other enzymes (eg, uridine diphosphate-glucuronosyltransferases, cytochrome P450 isozymes, nico
62 fam 03016 that is the hallmark of the beta-d-glucuronosyltransferase domain of exostosins, a class of
63 he enzyme shows sequence similarities to the glucuronosyltransferase domain of exostosins, a class of
64 mes P-450) and phase II (uridine diphosphate glucuronosyltransferases) drug-metabolizing enzymes are
66 ng developmental effects of a microsomal UDP-glucuronosyltransferase-encoding gene from pea (Pisum sa
67 he prostate may be to provide precursors for glucuronosyltransferase enzymes, which inactivate and so
68 one transferases, NAD(P)H:quinone reductase, glucuronosyltransferases, epoxide hydrolase) is a major
69 eterogeneity in uridine 5'-diphosphate (UDP) glucuronosyltransferase expression across the human hepa
71 tic inhibition of hepatic conjugation by UDP glucuronosyltransferase family 1 member A1 (UGT1A1), was
72 rved across a 200 kb region spanning the UDP-glucuronosyltransferase family, including UGT1A1, an enz
73 creases 1 (moca1), and identified MOCA1 as a glucuronosyltransferase for glycosyl inositol phosphoryl
76 y lacked UDP-glucuronic acid:Galbeta1,3Gal-R glucuronosyltransferase (GlcAT-I) activity, as measured
77 ich is transferred to the AGP glycan by beta-glucuronosyltransferases (GLCATs), is the only acidic su
78 thought to encode UDP-GlcUA:Galbeta1,3Gal-R glucuronosyltransferase (GlcUAT-I), involved in the form
79 tical to the UDP-GlcUA:glycoprotein beta1, 3-glucuronosyltransferase (GlcUAT-P) involved in forming H
80 the position-specific activity of the xylan glucuronosyltransferase GUX1, and so the even pattern of
81 Relocating either galactosyltransferase I or glucuronosyltransferase I had no effect on the other's l
82 d B3GAT3, B4GALT7, and SLC35B2, which encode glucuronosyltransferase I, galactosyltransferase I, and
83 nthetic enzymes: galactosyltransferase I and glucuronosyltransferase I, required for the formation of
84 udy the expression and regulation of beta1,3-Glucuronosyltransferase-I (GlcAT-I), a key enzyme regula
86 We recently discovered an Arabidopsis GIPC glucuronosyltransferase, INOSITOL PHOSPHORYLCERAMIDE GLU
87 e hydrolase, NAD(P)H: quinone reductase, and glucuronosyltransferases] is a powerful strategy for ach
89 hydrophobic region in the bilirubin-type UDP-glucuronosyltransferase isozyme was first uncovered as a
90 rs6742078 located in the uridine diphosphate-glucuronosyltransferase locus as an instrumental variabl
93 related detoxification enzymes, notably UDP-glucuronosyltransferases, suggesting a network of associ
94 attributed to metabolic deactivation by UDP-glucuronosyltransferases that were expressed in RASWT an
95 -HexUA were tested as substrates for various glucuronosyltransferases to better understand enzyme spe
98 stosterone/4-nitrophenol uridine diphosphate glucuronosyltransferase (UDPGT), and aryl sulfotransfera
99 emical and genetic information on vertebrate glucuronosyltransferases (UGATs), only limited informati
101 s associated with a reduction in hepatic UDP glucuronosyltransferase (UGT) 1A1 activity that can lead
103 constitutional genetic variation at the UDP-glucuronosyltransferase (UGT) 1A1 locus in breast cancer
104 olized solely through glucuronidation by UDP-glucuronosyltransferase (UGT) 1A1, it is now known that
105 nduce the bilirubin-metabolizing enzyme--UDP-glucuronosyltransferase (UGT) 1A1--to prevent the onset
106 quires the expression of uridine diphosphate glucuronosyltransferase (UGT) 1A1; we investigated its r
107 the rabbit liver dexamethasone-inducible UDP-glucuronosyltransferase (UGT) 2B13 RNA is related in seq
109 tigate the inhibitory effects of TKIs on UDP-glucuronosyltransferase (UGT) activities, and to quantit
110 dinavir-mediated impairment of bilirubin UDP-glucuronosyltransferase (UGT) activity and would be most
112 en glucuronidation, catalyzed by the two UDP-glucuronosyltransferase (UGT) enzymes UGT2B15 and UGT2B1
113 f the UGT1A gene, encoding half of human UDP-glucuronosyltransferase (UGT) enzymes, undergo alternati
118 A1) encoding the uridinediphosphoglucuronate glucuronosyltransferase (UGT) isoform bilirubin-UGT1 wer
119 ein-protein interactions between several UDP-glucuronosyltransferase (UGT) isoforms and cytochrome P4
125 (NQO1), glutathione S-transferase (GST), UDP-glucuronosyltransferase (UGT), and phenol sulfotransfera
126 hepatic glutathione S-transferase (GST), UDP-glucuronosyltransferase (UGT), and sulfotransferase (ST)
129 in vitro studies have suggested that the UDP-glucuronosyltransferases (UGT) 2B10 and 2B17 play major
133 gamma-glutamylcysteine synthetase (GCS), UDP-glucuronosyltransferases (UGT),epoxide hydrolase, as wel
135 iable exons arrayed in tandem, including UDP glucuronosyltransferase (UGT1), plectin, neuronal nitric
137 ioma-associated protein 1 (GLI1) and the UDP glucuronosyltransferase (UGT1A) family of enzymes are el
138 ler-Najjar syndrome model animal lacking UDP-glucuronosyltransferase (UGT1A1), was used as recipient.
143 f two androgen-inactivating enzymes, the UDP-glucuronosyltransferases UGT2B15 and UGT2B17, was assess
146 ficient in drug conjugation catalyzed by UDP-glucuronosyltransferases (UGTs) and now report on the ro
152 ity label [beta-32P]5-azido-UDP-GlcUA to UDP-glucuronosyltransferases (UGTs) in intact, but not in de
153 pid, reversible down-regulation of human UDP-glucuronosyltransferases (UGTs) in LS180 cells following
154 D-glucopyranosides (glucuronides) by the UDP-glucuronosyltransferases (UGTs) is a significant metabol
155 tor-activated receptor alpha (PPARalpha)-UDP-glucuronosyltransferases (UGTs) signalling is an importa
156 n liver microsomes and human recombinant UDP-glucuronosyltransferases (UGTs) was characterized and co
157 hepatic and intestinal uridine-5'-diphospho-glucuronosyltransferases (UGTs), the catalytic site of w
158 The UGT1A cluster encodes a family of UDP-glucuronosyltransferases (UGTs), which facilitate cellul
159 s highly metabolized by uridine-5'-diphospho-glucuronosyltransferases (UGTs), whose catalytic site is
167 cyclodeaminase, and the uridine diphosphate glucuronosyltransferases, whereas alleles such as DRB1*0
168 az both induce an unidentified rat liver UDP-glucuronosyltransferase with activity toward benzo(a)pyr